# Artio Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/artio-medical

- Industry: Medical Devices & Equipment
- Headquarters: Prairie Village, US
- Website: www.artio.com
- Total disclosed funding: $1.2M
- Latest round: Series A (Mar 8, 2018)
- Investors on record: 2

## About

Artio Medical Inc. focuses on medical device innovations, specifically developing embolization solutions to improve patient outcomes and enhance procedural efficiency in interventional radiology.Founded in 2013, Artio Medical Inc. is engaged in the development of medical devices, particularly the Solus GoldTM Embolization Device. The company is headquartered in Prairie Village, US. William Whitaker is a key founder, and the company has successfully completed 11 deals, with the most recent deal dated July 16, 2022. Artio Medical raised USD 11.40 mn in Series A funding, which represents the total amount raised.Artio Medical specializes in innovative medical devices, focusing on the development of embolization solutions designed to enhance the efficacy of interventional radiology procedures. Their flagship product, the Solus GoldTM Embolization Device, is engineered to provide improved performance for embolization applications. The company is committed to advancing its product portfolio to meet the evolving needs of medical professionals and patients.Artio Medical generates revenue primarily through the sale of its medical devices, including the Solus GoldTM Embolization Device. Revenue is accrued via direct sales to hospitals and healthcare providers engaged in interventional radiology and related fields. The company’s pricing strategy reflects the advanced technology and efficacy of its solutions, ensuring compatibility with the financial structures of healthcare providers.Artio Medical plans to leverage its recent Series A funding of USD 11.40 mn raised in June 2022 to support the commercialization of the Solus GoldTM Embolization Device in the US market. Additionally, the funding will facilitate the acceleration of the development of a broad portfolio of products, including enhancements to the company’s engineering and manufacturing capabilities. The company aims to expand its market reach, targeting further penetration in North America and exploring opportunities in Europe by 2024.

## Funding rounds

- Series A, Mar 8, 2018, $1.2M — Serra Ventures, Mid-America Angels

## Investors

- Serra Ventures (https://capitalatlas.ai/funds/serra-ventures) — Series A
- Mid-America Angels — Series A